Cancer survivors have been increasingly advocating for research into the long-term effects of their treatments. Some researchers working on cancer survivorship issues engage survivors productively with their teams, but many do not, negatively impacting innovation in this field. Cancer survivors must be included in every stage of this research process.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Improving the odds together: a framework for breast cancer research scientists to include patient advocates in their research
npj Breast Cancer Open Access 30 June 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
The American Cancer Society medical and editorial content team. Key Statistics for Childhood Cancers. ACS https://www.cancer.org/cancer/cancer-in-children/key-statistics.html (2022).
Hudson, M. M. et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 309, 2371–2381 (2013).
Hill, F. G. H. et al. Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172). Br. J. Haematol. 124, 33–46 (2004).
van der Plas, E. et al. Neurocognitive late effects of chemotherapy in survivors of acute lymphoblastic leukemia: focus on methotrexate. J. Can. Acad. Child Adolesc. Psychiatry. 24, 25–32 (2015).
Gibson, E. M. et al. Methotrexate chemotherapy induces persistent tri-glial dysregulation that underlies chemotherapy-related cognitive impairment. Cell 176, 43–55 (2019).
Hunter, B. D. & Jacobson, C. A. CAR T-cell associated neurotoxicity: mechanisms, clinicopathologic correlates, and future directions. J. Natl Cancer Inst. 111, 646–654 (2019).
Forster, V. J. et al. Drug interactions may be important risk factors for methotrexate neurotoxicity, particularly in pediatric leukemia patients. Cancer Chemother Pharmacol. 78, 1093–1096 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Forster, V.J. What cancer survivors can teach cancer researchers. Nat Rev Cancer 22, 431–432 (2022). https://doi.org/10.1038/s41568-022-00468-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41568-022-00468-z